Breathing Difficulty Still Common in Hospitalized COVID-19 Patients After 6 Months
ew survey
ew survey
FDA approves mavorixafor (XOLREMDI) for WHIM syndrome, the first approved treatment for the rate disease.
The biosimilars month in review reflects ongoing efforts to address key challenges in rheumatic disease treatment.
Findings showed the light microscopy pattern of glomerular injury and the intensity of mesangial C3 deposition may refine the histological assessment of IgAN.
This analysis indicates that quantitative interstitial abnormalities may indicate alterations in lung tissue processes that can result in short- and long-term consequences as far as…
A new study highlights the importance of daily antioxidant intake for endometriosis-related RA.
Payal Kohli, MD, discusses how recent advancements have changed conversations surrounding modifiable cardiovascular risk and what it means for practitioners.
Patients in the Mediterranean diet group reported improvements in most fibromyalgia measures, including anxiety, fatigue, and disability scores.
This analysis indicates that quantitative interstitial abnormalities may indicate alterations in lung tissue processes that can result in short- and long-term consequences as far as…
Our April month in review for hematology breaks down the latest updates to the pipeline, mortality risk in people with sickle cell disease, and our…
These data suggest vaping poses potential threats to the development of the brain and organs, with teenagers being a predominant target due to surges in…